Previous close | 48.00 |
Open | 48.00 |
Bid | 48.00 x 0 |
Ask | 51.90 x 0 |
Day's range | 48.00 - 48.00 |
52-week range | 32.80 - 64.40 |
Volume | |
Avg. volume | 1,156 |
Market cap | 328.206M |
Beta (5Y monthly) | 2.18 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.79 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Company Announcement, Inside information, Helsinki, 17 May 2022 at 10:15 AM (EEST) Nexstim agrees with Dr. Joshua Kuluva on a minority interest in the private equity company established previously Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announced on 11 March 2022 that the Company’s US subsidiary Nexstim, Inc. has established a private equity company. The purpose of the private equity company is to further expand the network of Nexstim neuroscience centers in the US. The Compa
Press release, Helsinki, 27 April 2022 at 9:30 AM (EEST) Nexstim Plc Business and Clinical Update Q1 2022 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the key highlights of the Company’s business and clinical operations during Q1 2022. CEO Mikko Karvinen’s Business and Clinical Update I’m very happy to say that following the strongest year in the history of the company, our business has continued to show unprecedented positive progress during the first quarter of 2022. I
Company Announcement, Helsinki, 14 April 2022 at 3:00 PM (EEST) Nexstim Plc: Managers’ Transactions, Hildén Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces managers’ transactions as follows: Person subject to the notification requirementName: Timo HildénPosition: Member of the Board/Deputy member Issuer: Nexstim OyjLEI: 743700S7ZI0LNMHZ6Y27Notification type: INITIAL NOTIFICATIONReference number: 13303/7/6____________________________________________ Transaction date: 2022-04